Varun Saxena

Varun Saxena
Varun Saxena

Varun Saxena, News Editor

Varun Saxena is a news editor for Fierce Life Sciences. He edits and writes for FierceMedicalDevices and FierceDrugDelivery. Prior to joining Fierce he covered the medical device and diagnostics industry for "The Gray Sheet." He has had stints at The Indianapolis Star, the Chronicle of Higher Education and Kiplinger's Personal Finance magazine. Varun is a graduate of George Washington University, from which he earned a Bachelor's in Economics. In addition, he has a Master's in Journalism from the University of Maryland.He is a member of the National Press Club and the South Asian Journalists Association. In his free time, he enjoys playing sports on the mall. Follow Varun on Twitter @VarunSaxena2 or email him at [email protected].

Stories by Varun Saxena

FDA encourages generic abuse-deterrent opioids

The FDA released a draft guidance requiring that generic version of abuse-deterrent opioids are at least as difficult to manipulate as the original med, as it ramps up its efforts again the prescription medication abuse epidemic, which has been implicated in the startlingand unprecedented rise of the death rateamong middle-aged white Americans.

Vygon opens Portuguese plant for chemotherapy devices

Ecouen, France's Vygon announced the completion of a €7 million ($8 million) 25,000 square meter in Paredes, Portugal to manufacture its drug delivering oncology devices. It intends to create more than 120 jobs in the area over the next five years.

Capsugel eyeing IPO or sale for $5B+

Drug-delivering capsule maker Capsugel is eyeing a sale or IPO worth more than $5 billion including debt, which would represent a more than doubling of the price paid by its private equity owner KKR in 2011, when it acquired the company from Pfizer.